Attention: open in a new window. E-mailPrintPDF
Drug manufacturers investing in Poland can count on PLN400m in support from a new developmental reimbursement scheme (RTR). The work on RTR started already in 2016 as part of cooperation…

Order subscription to read this article

 

Login


Subscribe

Order at PNB.pl
Order from our partners:
Nexto.pl


Call us:

Find us: